← Back to Search

Longitudinal assessment for Healthy Aging

N/A
Waitlist Available
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to provide written informed consent
60 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6-month follow-up, 12-months follow-up
Awards & highlights

Study Summary

This trial aims to improve the prediction of falls in patients with Parkinson's disease by measuring walking, cognitive, and functional performances over time.

Eligible Conditions
  • Healthy Aging
  • Parkinson's Disease

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6-month follow-up, 12-months follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6-month follow-up, 12-months follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in scaling exponent of stride time series every 6-months
Falls and near falls
Secondary outcome measures
Change in gait biomechanics every 6-months

Trial Design

1Treatment groups
Experimental Treatment
Group I: Longitudinal assessmentExperimental Treatment1 Intervention
Participants will take part in a baseline study session, followed by a year of weekly reports of their number of near falls and falls. The same participants will repeat the same study session six months and twelve months after the baseline session.

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
535 Previous Clinical Trials
1,143,883 Total Patients Enrolled
National Institute of General Medical Sciences (NIGMS)NIH
268 Previous Clinical Trials
248,881 Total Patients Enrolled
Nicholas Stergiou, PhDStudy DirectorUniversity of Nebraska
2 Previous Clinical Trials
50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Mar 2025